Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2013 5
2014 3
2016 1
2018 2
2019 1
2020 2
2021 4
2022 1
2023 4
2024 1
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, Inkman MJ, Ghosh S, Ruiz F, Jayachandran K, Huang Y, Luo J, Zhang J, Cosper P, Luke CJ, Spina CS, Grigsby PW, Schwarz JK, Markovina S. Chen L, et al. Among authors: spina cs. J Clin Invest. 2023 Aug 1;133(15):e163841. doi: 10.1172/JCI163841. J Clin Invest. 2023. PMID: 37279067 Free PMC article.
Mechanisms of Immune Modulation by Radiation.
Spina CS, Drake CG. Spina CS, et al. Semin Radiat Oncol. 2021 Jul;31(3):205-216. doi: 10.1016/j.semradonc.2021.02.001. Semin Radiat Oncol. 2021. PMID: 34090647 Review.
Vitamin D and cancer.
Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Spina CS, et al. Anticancer Res. 2006 Jul-Aug;26(4A):2515-24. Anticancer Res. 2006. PMID: 16886659 Free article. Review.
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.
Ager CR, Obradovic A, McCann P, Chaimowitz M, Wang ALE, Shaikh N, Shah P, Pan SS, Laplaca CJ, Virk RK, Hill JC, Jugler C, DeFranco G, Bhattacharya N, Copple KR, Scher HI, DeCastro GJ, Anderson CB, McKiernan JM, Spina CS, Stein MN, Runcie K, Drake CG, Califano A, Dallos MC. Ager CR, et al. Among authors: spina cs. medRxiv [Preprint]. 2025 Mar 31:2024.09.09.24313308. doi: 10.1101/2024.09.09.24313308. medRxiv. 2025. PMID: 39314954 Free PMC article. Preprint.
Combined local and systemic attacks.
Spina CS, Drake CG. Spina CS, et al. Nat Biomed Eng. 2018 Aug;2(8):564-565. doi: 10.1038/s41551-018-0277-z. Nat Biomed Eng. 2018. PMID: 31015639 No abstract available.
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
Ager CR, Obradovic A, McCann P, Chaimowitz M, Wang ALE, Shaikh N, Shah P, Pan SS, Laplaca CJ, Virk RK, Hill JC, Jugler C, DeFranco G, Bhattacharya N, Copple KR, Nguyen P, Scher HI, DeCastro GJ, Anderson CB, McKiernan JM, Spina CS, Stein MN, Runcie K, Drake CG, Califano A, Dallos MC. Ager CR, et al. Among authors: spina cs. Cell Rep Med. 2026 Mar 17;7(3):102638. doi: 10.1016/j.xcrm.2026.102638. Epub 2026 Feb 26. Cell Rep Med. 2026. PMID: 41759531 Free PMC article. Clinical Trial.
Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
Spina CS, Tsuruoka C, Mao W, Sunaoshi MM, Chaimowitz M, Shang Y, Welch D, Wang YF, Venturini N, Kakinuma S, Drake CG. Spina CS, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):813-818. doi: 10.1016/j.ijrobp.2020.09.053. Epub 2020 Nov 13. Int J Radiat Oncol Biol Phys. 2021. PMID: 33190969
27 results